Pfizer's Xalkori picks up FDA 'breakthrough' tags in lung cancer, lymphoma
admin 29th May 2018 Uncategorised 0Pfizer’s Xalkori has picked up two FDA breakthrough designations, one for certain lung cancer patients and another in a rare form of lymphoma.
More: Pfizer's Xalkori picks up FDA 'breakthrough' tags in lung cancer, lymphoma
Source: fierce